Phase III ALTU-135 CP Safety Trial

Clinical trial NCT00500084 · TERMINATED

Trial details

NCT number: NCT00500084
Sponsor: Anthera Pharmaceuticals
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Exocrine Pancreatic Insufficiency

Start date: 2007-12-01
Primary completion: 2009-03-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.